Targeting Myeloid-Derived Suppressor Cells in the Treatment of Hepatocellular Carcinoma: Current State and Future Perspectives

Journal of Hepatocellular Carcinoma
doi 10.2147/jhc.s159693
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H22 Hepatocellular Carcinoma-Bearing Mice: By Targeting Myeloid-Derived Suppressor Cells

Frontiers in Pharmacology
Pharmacology
2020English

Regulation of Accumulation and Function of Myeloid Derived Suppressor Cells in Different Murine Models of Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2013English

Myeloid-Derived Suppressor Cells Correlate With Patient Outcomes in Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2016English

Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Increase in CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients and Its Impact on Prognosis

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2013English

Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future

Clinical Liver Disease
Hepatology
2019English

HMGB1 Promotes Myeloid-Derived Suppressor Cells and Renal Cell Carcinoma Immune Escape

Oncotarget
Oncology
2017English

MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1

Journal of Immunology
AllergyImmunology
2015English

Myeloid-Derived Suppressor Cells in Autoimmune Diseases

Inflammation and Regeneration
AllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy